Effects of Long Term Use of Antiretroviral Therapy on the Oral Mucosa (R01)
The summary for the Effects of Long Term Use of Antiretroviral Therapy on the Oral Mucosa (R01) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Effects of Long Term Use of Antiretroviral Therapy on the Oral Mucosa (R01): The purpose of this Initiative is to stimulate research on the long term effects of antiretroviral therapy (ART) on, for example, the qualitative and quantitative composition of the saliva, innate and adaptive immune networks of the oral mucosa, and oral epithelial structures and functions. Such research will provide valuable insight into the cellular and molecular mechanisms responsible for occurrence or re-occurrence of oral disorders in HIV infected/AIDS patients, despite having been treated with ART. A goal of the initiative is to identify novel strategies for prevention and management of oral manifestations of HIV infection and AIDS by reducing the negative effects of ART.
Federal Grant Title: | Effects of Long Term Use of Antiretroviral Therapy on the Oral Mucosa (R01) |
Federal Agency Name: | National Institutes of Health |
Grant Categories: | Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | RFA-DE-07-002 |
Type of Funding: | Grant |
CFDA Numbers: | 93.121 |
CFDA Descriptions: | Oral Diseases and Disorders Research |
Current Application Deadline: | No deadline provided |
Original Application Deadline: | Aug 12, 2006 |
Posted Date: | Mar 02, 2006 |
Creation Date: | Mar 02, 2006 |
Archive Date: | Sep 11, 2006 |
Total Program Funding: | $1,300,000 |
Maximum Federal Grant Award: | |
Minimum Federal Grant Award: | |
Expected Number of Awards: | 4 |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- Native American tribal organizations (other than Federally recognized tribal governments) Public housing authorities/Indian housing authorities State governments City or township governments County governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts Special district governments Others (see text field entitled "Additional Information on Eligibility" for clarification) Public and State controlled institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education For profit organizations other than small businesses Native American tribal governments (Federally recognized)
- Additional Information on Eligibility
- Foreign institutions are eligible to apply. Eligible agencies of the Federal Government are eligible to apply.
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- NIH OER Webmaster
[email protected]
[email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster - Similar Government Grants
- • HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggabl...
- • NIDCR Predoctoral to Postdoctoral Transition Award to Promote a Diverse Dental, Oral and C...
- • Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research ...
- • HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allow...
- • NIDCR Mentoring Network to Promote a Diverse Dental, Oral and Craniofacial Research Workfo...
- • Epidemiological and Behavioral Research in Oral Health
- • Metagenomic Analyses of the Oral Microbiome
- • Phase Iii Clinical Trials in Oral Infectious Diseases
- More Grants from the National Institutes of Health
- • Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Tri...
- • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...
- • HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggabl...
- • Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical T...
- • Global Infectious Disease Research Training Program (D43 Clinical Trial Optional)